Understanding the Global Cancer Statistics 2018: implications for cancer control

Cancer incidence and mortality increase rapidly worldwide, making cancer the major cause of death in most regions. Understanding the current cancer burden in different regions is necessary to find out potential risk factors and generate strategies for cancer control. The International Agency for Research on Cancer (IARC) has recently provided a status report about the global burden of cancer by estimating the incidence and mortality for 36 cancers in 185 countries (Bray et al., 2018). In this article, we will summarize the distribution of the major cancer types in different regions and reveal the global cancer pattern. In addition, we will stress the potential risk factors responsible for the increase of cancer burden and the importance of medical allocation for cancer control.

[1]  J. Lagergren,et al.  The Epidemiology of Esophageal Adenocarcinoma. , 2017, Gastroenterology.

[2]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[3]  M. Parascandola,et al.  Provincial-level cancer burden attributable to active and second-hand smoking in China , 2018, Tobacco Control.

[4]  John Kidd,et al.  Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Jemal,et al.  The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections , 2016, CA: a cancer journal for clinicians.

[6]  Ahmedin Jemal,et al.  Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States , 2018, CA: a cancer journal for clinicians.

[7]  S. Bialous,et al.  Exposing and addressing tobacco industry conduct in low-income and middle-income countries , 2015, The Lancet.

[8]  L. Learman,et al.  Screening for Cervical Cancer: New Tools and New Opportunities. , 2018, Journal of the American Medical Association (JAMA).

[9]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[10]  S. Fedewa,et al.  Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening , 2018, CA: a cancer journal for clinicians.

[11]  M. McCullough,et al.  A blueprint for the primary prevention of cancer: Targeting established, modifiable risk factors , 2018, CA: a cancer journal for clinicians.

[12]  A. Alberg,et al.  Alcohol and Cancer: A Statement of the American Society of Clinical Oncology. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Hong-Yang Wang.  Non-resolving inflammation and cancer , 2017, Science China Life Sciences.

[14]  J. Gohagan,et al.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. , 2012, Journal of the National Cancer Institute.

[15]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[16]  Jill O Jin.  Screening for Cervical Cancer. , 2018, JAMA.

[17]  Sarah P Zuber,et al.  Screening for Cervical Cancer , 2012 .

[18]  C Milligan,et al.  Screening for cervical cancer. , 1975, The American journal of nursing.

[19]  H. Brenner,et al.  Healthy Lifestyle Factors Associated With Lower Risk of Colorectal Cancer Irrespective of Genetic Risk. , 2018, Gastroenterology.

[20]  W. Wang,et al.  Booming cancer immunotherapy fighting tumors , 2017, Science China Life Sciences.

[21]  C. Abnet,et al.  Epidemiology of Esophageal Squamous Cell Carcinoma. , 2017, Gastroenterology.